home / stock / ntra / ntra news


NTRA News and Press, Natera Inc. From 07/23/19

Stock Information

Company Name: Natera Inc.
Stock Symbol: NTRA
Market: NASDAQ
Website: natera.com

Menu

NTRA NTRA Quote NTRA Short NTRA News NTRA Articles NTRA Message Board
Get NTRA Alerts

News, Short Squeeze, Breakout and More Instantly...

NTRA - Making Fundamental Sense Out Of What Some Might See As Fanciful Speculation

What do you think about when you encounter the phrase “swing trade.” Buy at the bottom of a stock’s trading range and then sell at the top. Yeah, right. Who doesn’t want to do that! Often, though, such aspirations translate to fanciful daydreaming, especially whe...

NTRA - New ProActive(TM) Study From Natera Will Test for Rejection in 3,000 Kidney Transplant Recipients

SAN CARLOS, Calif. , June 24, 2019 /PRNewswire/ --   Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a nationwide registry study for kidney transplant recipients called ProActive. This is one of the largest known prospective studies to date, i...

NTRA - Data Presented at ASCO Shows Natera's Signatera Test Detects Immunotherapy Treatment Response in Metastatic Cancers

SAN CARLOS, Calif. , June 3, 2019 /PRNewswire/ -- A new study demonstrates the ability of Natera's Signatera™ test to assess patient response to immunotherapy in the metastatic setting across multiple cancer types by detecting molecular traces of circulating tumor DNA (ctDNA) in th...

NTRA - Noridian Posts Favorable Draft Local Coverage Determination for Natera's Prospera(TM) Kidney Transplant Test

SAN CARLOS, Calif. , May 21, 2019 /PRNewswire/ -- Noridian, the Medicare Administrative Contractor (MAC) for California -based laboratories, has posted a favorable draft local coverage determination (LCD) for use of Natera 's Prospera™ test to assess active rejection in kidney ...

NTRA - Guardant Health: Competitors Are Trading At Cheaper Valuations

After the IPO, Guardant Health ( GH ) delivered 133% returns. As of May 14, 2019, it sells at 38x forward sales. Other peers are trading at cheaper valuations. The market expects additional revenue from the company’s new early detection program. It explains why the EV/Forward sales rati...

NTRA - Natera, Inc. (NTRA) CEO Steve Chapman on Q1 2019 Results - Earnings Call Transcript

Natera, Inc. (NTRA) Q1 2019 Earnings Conference Call May 09, 2019 04:30 PM ET Company Participants Michael Brophy - Chief Financial Officer Paul Billings - Chief Medical Officer and Senior Vice President of Medical Affairs Solomon Moshkevich - General Manager of Oncology & Tr...

NTRA - Natera, Inc. 2019 Q1 - Results - Earnings Call Slides

The following slide deck was published by Natera, Inc. in conjunction with their 2019 Q1 earnings Read more ...

NTRA - BPL, GH, PBYI and JMIA among notable midday movers

Gainers:  Charles & Colvard (NASDAQ: CTHR ) +34% . Buckeye Partners (NYSE: BPL ) +28% . Cardlytics (NASDAQ: CDLX ) +26% . G1 Therapeutics (NASDAQ: GTHX ) +24% . Westport Fuel Systems (NASDAQ: WPRT ) +21% . Cool Holdings (NASDAQ: AWSM ) +22% . Guardant Health (NASDAQ: GH ) +...

NTRA - Natera beats by $0.06, beats on revenue

Natera (NASDAQ: NTRA ): Q1 GAAP EPS of -$0.54 beats by $0.06 . More news on: Natera, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

NTRA - Natera Reports First Quarter 2019 Financial Results

SAN CARLOS, Calif. , May 9, 2019 /PRNewswire/ -- Natera, Inc.  (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results for the first quarter ended March 31, 2019 and provided an update on rec...

Previous 10 Next 10